JOHNSON & JOHNSON’s organizational structure is dictated by its corporate strategy. Johnson & Johnson has more than 250 companies located in 60 countries around the world. Johnson & Johnson Family of Companies is organized into several business segments comprised of franchises and therapeutic categories.
Consumer HealthcareThe Consumer segment includes a broad range of products used in the baby care, skin care, oral care, wound care and women’s health care fields, as well as nutritional and over-the-counter pharmaceutical products, and wellness and prevention platforms. Medical Devices & DiagnosticsThe Medical Devices & Diagnostics business segment produces a broad range of innovative products and solutions used primarily by health care professionals in the fields of orthopedics, neurological disease, vision care, diabetes care, infection prevention, diagnostics, cardiovascular disease, and aesthetics. This segment is comprised of their Global Medical Solutions, Global Orthopedics and Neurological, and Global Surgery Groups.
PharmaceuticalsThe Janssen Pharmaceutical Companies of Johnson & Johnson are dedicated to addressing and solving the most important unmet medical needs of their time, including oncology (e.g., multiple myeloma and prostate cancer), immunology (e.g., rheumatoid arthritis, irritable bowel disease and psoriasis), neuroscience (e.g., schizophrenia, dementia and pain), infectious disease (e.g., HIV/AIDS, Hepatitis C and tuberculosis), and cardiovascular and metabolic diseases (e.g., diabetes). Driven by their commitment to patients, they develop sustainable, integrated healthcare solutions by working side-by-side with healthcare stakeholders, based on partnerships of trust and transparency.
Initially JOHNSON & JOHNSON adopted a decentralized approach to management but in the early 1900s, changed it to a more standardized approach for JOHNSON & JOHNSON’s top